Related Experiment Video
Updated: Aug 9, 2026

07:22
Quantitative Fundus Autofluorescence for the Evaluation of Retinal Diseases
Published on: March 11, 2016
[Sorsby's fundus dystrophy: a literature review]
1Center for Chronic Viral Diseases, Kagoshima University Faculty of Medicine, Japan.
Nippon Ganka Gakkai Zasshi
|February 26, 1999
Summary
Sorsby's fundus dystrophy (SFD) is a genetic eye disease. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP 3) gene cause SFD, enabling accurate diagnosis and future therapies.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Context:
- Sorsby's fundus dystrophy (SFD) is an autosomal dominant macular dystrophy.
- SFD shares clinical similarities with age-related macular degeneration.
- The genetic basis of SFD has recently been elucidated.
Purpose:
- To review the clinical and molecular aspects of Sorsby's fundus dystrophy.
- To highlight the identification of the causative gene in SFD.
- To emphasize the diagnostic and therapeutic implications of genetic findings.
Summary:
- SFD presents with macular lesions and peripheral chorioretinal dystrophy, leading to vision loss.
- The disease typically manifests in the fourth or fifth decade of life.
- Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP 3) gene are identified as the cause of SFD.
Impact:
- TIMP 3 gene analysis facilitates accurate SFD diagnosis.
- Genetic identification paves the way for developing therapeutic strategies.
- Understanding the molecular basis of SFD aids in differentiating it from similar conditions.
Related Concept Videos
Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Barrett Esophagus-I: Introduction
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...

